Device Trial Radar · NCT07432191
Medical Device Clinical Trial Without CE Marking to Evidence Safety and Performance of the INBENTUS VERSATILE Ventilator in Patients Requiring Assisted/Controlled Mechanical Ventilation and Weaning.
Last checked: Nov 20, 2026Latest source record: Sep 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
81
Planned (sponsor's estimate)
Start
May 29, 2025
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Iconic Solutions By Murcia SLNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Hospital Universitario Virgen de la Arrixaca; Iberania Contract Research
- First posted
- Feb 25, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Supportive care
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Pre-market clinical trial on 81 aldults participants to evidence safety and performance of the non-CE-marked medical device INBENTUS VERSATILE ventilator. The 81 aldult participants are ventilated between 3 and 48 hours with invasive mechanical ventilation (IMV) in assisted/controlled mode and weaning under partial pressure support or volume support, followed by monitoring period until ICU discharge, hospital discharge or 30 days. The study design differentiates between a Validation Cohort (up to 20 participants) for device validation and a Study Cohort (up to 61 participants) for safety and performance confirmation. Serious Adverse Events related to study device and/or its procedure is defined as the primary safety endpoint, whereas technical failure rate is defined as the primary performance endpoint.
Conditions
- Acute Respiratory Distress Syndrome (ARDS)
- Pneumonia
- COPD (Chronic Obstructive Pulmonary Disease)
- Postoperative Respiratory Distress
- Hypoventilation Syndrome
- Hypoxemia
- Hypercapnia
Interventions
INBENTUS VERSATILEDevice
INBENTUS VERSATILE ventilation according to protocol specifications and clinical needs
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Safety EndpointTime frame: From 3 to 48 hours of mechanical ventilation under the study device
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital Universitario Virgen de la Arrixaca
Murcia, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.